ExchangeRates.org.uk - The Pound Euro ( GBP/EUR) exchange rate rallied from a 13-day low on Tuesday as forecast-beating UK ...

Despite the market’s positive reaction to the possibility of activist involvement, Faber cautioned that Comcast might present ...

Investing.com -- Morgan Stanley upgraded Roku to Overweight from Underweight in a note on Tuesday, citing a more constructive ...

Inflationary pressure on operating expenses is also described as “more normalised,” making mitigation easier than in recent years. Within this backdrop, JPMorgan reiterates Marks & Spencer as its ...

The company, which specializes in what it calls "Agentic Commerce," revealed in preliminary unaudited year-end results that it anticipates exiting 2025 with Annual Recurring Revenue (ARR) exceeding ...

Investing.com -- China’s largest coffee chain Luckin Coffee Inc. is exploring a potential bid for Nestle SA ’s Blue Bottle Coffee as part of a strategy to enhance its brand profile and expand in the ...

Jefferies maintained a Buy rating and $1,150 price target on NOW, with Samana concluding: “We understand fears of a shift away from a ’tuck-in’ focused M&A strategy, but we see this as NOW ...

Looma’s in-store network has grown exponentially since 2023, surging from 800 screens to more than 7,000 screens across 1,100 retail locations. The platform now reaches 27 million shoppers a month ...

Investing.com -- Polish Prime Minister Donald Tusk announced Tuesday that European Union countries will invest heavily in developing defenses against drones, which has become a priority for the bloc.

Inflation in Morocco has remained low, averaging 0.8% over the first ten months of 2025, driven by improved food product supply, particularly olive oil, and decreased fuel prices. The central bank ...

The report found that the number of job losses in August was revised down by 22,000 to 26,000, while the total amount of jobs added in September was brought down to 108,000. With the revisions, ...

AstraZeneca PLC (ST:AZN) received European Union approval for Saphnelo (anifrolumab) as a subcutaneous self-administration option for adult patients with systemic lupus erythematosus. The approval ...